WallStreetZenWallStreetZen

NASDAQ: RNA
Avidity Biosciences Inc Stock Ownership - Who owns Avidity Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Avidity Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael F. MacLeanChief Financial Officer2026-01-212,735$72.45
$198.15kSell
Sarah BoycePresident and CEO2026-01-216,394$72.45
$463.25kSell
Sarah BoycePresident and CEO2026-01-217,993$72.45
$579.09kSell
Steven George HughesChief Medical Officer2026-01-212,017$72.45
$146.13kSell
Steven George HughesChief Medical Officer2026-01-212,878$72.45
$208.51kSell
Arthur A. LevinDirector2026-01-211,758$72.45
$127.37kSell
W. Michael FlanaganChief Scientific Officer2026-01-213,976$72.45
$288.06kSell
W. Michael FlanaganChief Scientific Officer2026-01-212,558$72.45
$185.33kSell
Michael F. MacLeanChief Financial Officer2026-01-211,807$72.45
$130.92kSell
Teresa McCarthyChief Human Resources Officer2026-01-211,453$72.45
$105.27kSell

1 of 11

RNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNA insiders and whales buy or sell their stock.

RNA Shareholders

What type of owners hold Avidity Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.33%21,585,984$1.57BInstitution
Janus Henderson Group PLC9.64%14,522,915$1.05BInstitution
Vanguard Group Inc8.77%13,219,759$959.36MInstitution
Rtw Investments LP7.55%11,372,829$825.33MInstitution
Wellington Management Group LLP6.68%10,065,187$730.43MInstitution
Price T Rowe Associates Inc6.50%9,787,417$710.27MInstitution
Blackrock Inc6.11%9,202,579$667.83MInstitution
Rtw Investments LP5.83%8,790,000$637.89MInsider
Ra Capital Management LP5.73%8,641,031$627.08MInstitution
Avoro Capital Advisors LLC5.07%7,645,000$554.80MInstitution

1 of 3

RNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNA90.28%9.72%Net SellingNet Selling
BMRN93.36%1.74%Net SellingNet Selling
EXEL93.47%5.49%Net SellingNet Selling
SMMT7.35%92.65%Net Buying
MDGL26.01%73.99%Net BuyingNet Selling
View Top Biotech Stocks

Avidity Biosciences Stock Ownership FAQ

Who owns Avidity Biosciences?

Avidity Biosciences (NASDAQ: RNA) is owned by 106.83% institutional shareholders, 11.50% Avidity Biosciences insiders, and 0.00% retail investors. Rtw Investments LP is the largest individual Avidity Biosciences shareholder, owning 8.79M shares representing 5.83% of the company. Rtw Investments LP's Avidity Biosciences shares are currently valued at $637.89M.

If you're new to stock investing, here's how to buy Avidity Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.